PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Dexamethasone - Congenital adrenal hyperplasia

PAD Profile : Dexamethasone - Congenital adrenal hyperplasia Important

Keywords :
CAH
Important Information :
See PAD for guidance on providing reserve supplies for dosing during acute illness

Traffic Light Status

Status 1 of 2.

Status :
Blue
Important
Formulations :
  • Tablets
Important Information :
2nd line option. Requests for primary care prescribing on recommendation from specialist endocrinology team only.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 2.

Status :
Blue
Important
Formulations :
  • Oral solution
Important Information :
Reserved for patients who are unable to swallow solid dose forms. Requests for primary care prescribing by the specialist endocrinology teams only.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
05 March 2025
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) agrees the following place in therapy for glucocorticoids in line with NG243 (Adrenal insufficiency: identification and management)

  • Hydrocortidsone immediate release is the first choice glucocorticoid.
  • Prednisolone is an alternative first line if multiple daily doses are not appropriate.
  • Hydrocortisone modified-release is a 2nd line option
  • Dexamethasone is a 2nd line option
  • Fludrocortisone for mineralocorticoid replacement if needed (to normalise serum electrolytes and plasma renin, and reduce postural symptoms and salt craving)

See Formulary status and restrictions for individual formulations.

Dosing of glucocorticoids during acute illness - It is important for people with adrenal insufficiency to increase their corticosteroid doses at times of illness in order to reduce the risk of adrenal crisis. As a guide, for any moderate intercurrent illness (such as illness with fever, requiring bedrest, or requiring antibiotics), they should double their usual doses of Hydrocortisone until recovered, or if on Prednisolone, they should increase to a minimum dose of 10 mg daily (or follow specific advice as recommended by their specialist).

In order to allow patients to promptly increase their corticosteroid dose at times of need, and to avoid any risk from unexpected supply shortages, patients should ideally retain 2 months reserve supply at all times and should be reminded to renew their prescription in good time.

Associated BNF Codes

06. Endocrine System
06.03.02. Glucocorticoid therapy
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More